☰
✕
UA RU EN

Flexible CaroFlex Implant Developed in Pennsylvania Offers Suture-Free Blood Pressure Reduction

Інноваційний імплантат CaroFlex, створений у Пенсильванії, забезпечує зниження артеріального тиску без швів. Photo: НВ — Техно

The Innovative CaroFlex Implant

Researchers from Pennsylvania State University have engineered a groundbreaking flexible implant named CaroFlex that lowers blood pressure through electrical stimulation without requiring sutures. During trials on rats, the device successfully reduced blood pressure by over 15%. These promising findings were published in the journal Device on May 5, 2026. The next phase involves refining the technology and initiating clinical trials in humans.

Design and Features of CaroFlex

About the size of a fingertip, CaroFlex attaches directly to the artery, eliminating the need for stitches. Made primarily from hydrogel—a jelly-like substance—this implant is both flexible and lightweight. Scientists tested five different electrical pulse frequencies, with four successfully lowering arterial pressure. The device is placed near the carotid sinus, at the bifurcation of the carotid artery.

CaroFlex incorporates electrically conductive hydrogel electrodes combined with an adhesive layer that allows it to stick securely without sutures or toxic chemicals. The implant material can stretch to more than twice its original size before tearing, while the adhesive maintains strong bonding to tissue even after six months of storage. Studies revealed no tissue damage or immune reactions two weeks post-implantation.

Approximately 10% of patients with hypertension suffer from forms resistant to medication. Although CaroFlex has yet to be tested as a treatment in human patients, advances in 3D printing technology enabled its complex components to be integrated into a single flexible device, paving the way for future improvements and clinical use.

This development represents a significant advancement in managing hypertension, especially for those who do not respond to conventional drug therapies. While animal studies highlight the implant’s potential, rigorous human clinical trials are essential to verify its safety and effectiveness. Considering the growing global challenge of high blood pressure, innovations like CaroFlex may greatly enhance patient outcomes and quality of life.